Mannkind received its $150 M check from Sanofi on Sept 29, has access to $205 M in lines of credits (Sanofi and Mann), has an approved product about to be launched to help the 29 M Americans with diabetes, and has 2 big backers (Mann and Deerfield)...
If think you should trust your gut.
Institutional investors were already starting to come in q2.